Top Markets
Coin of the day
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Clasificación en acciones #33378
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Precio por acción
$0.05124204
Capitalización bursátil
$7.78M
Cambio (1 día)
0.51%
Cambio (1 año)
-23.73%
País
CH
Comercio Addex Therapeutics Ltd (ADXN)

Categoría

Historial del precio de la acción de Addex Therapeutics Ltd (ADXN)
Precio más alto de cierre: $0.05 el 2026-08-01

Precio más bajo de cierre: $54.79 el 2007-05-01
Historial del precio de la acción de Addex Therapeutics Ltd desde 2007 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -6.77%
2025 5.69%
2024 28.65%
2023 -59.04%
2022 -89.21%
2021 -42.01%
2020 15.05%
2019 -25.63%
2018 1.94%
2017 22.36%
2016 -37.32%
2015 15.45%
2014 -35.66%
2013 -62.43%
2012 68.65%
2011 -41.91%
2010 -59.41%
2009 -21.49%
2008 -3.22%
2007 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$734.30 6.85%
CH
$1.07K -6.40%
KR
$255.97 13.59%
BE